Refine
Year of publication
Document Type
- Doctoral Thesis (39)
Has Fulltext
- yes (39)
Is part of the Bibliography
- no (39)
Keywords
- Autism Spectrum Disorder (1)
- CNV 16p11.2 (1)
- Cardiac regeneration (1)
- Cerebral cortex (1)
- Connectomics (1)
- Coronaries (1)
- Development (1)
- EphrinB2 (1)
- Excitatory balance (1)
- Extracellular matrix (1)
Institute
ß1-integrins are essential for angiogenesis but the mechanisms regulating integrin function in endothelial cells (EC) and their contribution to angiogenesis remain elusive. BRAG2 is a guanine nucleotide exchange factor for the small Arf-GTPases Arf5 and Arf6. The role of BRAG2 in EC and angiogenesis and the underlying molecular mechanisms remains unclear. siRNA-mediated BRAG2-silencing reduced EC angiogenic sprouting and migration. BRAG2-siRNA-transfection differentially affected a5ß1- and aVß3-integrin function: specifically, BRAG2-silencing increased focal/fibrillar adhesions and EC adhesion on ß1-integrin-ligands (fibronectin and collagen), while reducing the adhesion on the aVß3-integrin-ligand, vitronectin. Consistent with these results, BRAG2-silencing enhanced surface expression of a5ß1-integrin, while reducing surface expression of aVß3-integrin. Mechanistically, BRAG2 mediated recycling of aVß3-integrins and endocytosis of ß1-integrins and specifically of the active/matrix bound a5ß1-integrin present in fibrillar/focal adhesions (FA), suggesting that BRAG2 contributes to the disassembly of FA via ß1-integrin-endocytosis. Arf5 and Arf6 are promoting downstream of BRAG2 angiogenic sprouting, ß1-integrin-endocytosis and the regulation of FA. In vivo silencing of the BRAG2-orthologues in zebrafish embryos using morpholinos perturbed vascular development. Furthermore, in vivo intravitral injection of plasmids containing BRAG2-shRNA reduced pathological ischemia-induced retinal and choroidal neovascularization. These data reveals that BRAG2 is essential for developmental and pathological angiogenesis by promoting EC sprouting through regulation of adhesion by mediating ß1-integrin internalization and associates for the first time the process of ß1-integrin endocytosis with angiogenesis.
In recent years, several neuronal differentiation protocols were published that circumvent the requirement of embryoid body (EB) formation under serum-deprivation and simplified medium conditions. But a neuronal default model to establish an approach that works efficiently for all pluripotent cells and neuronal precursors is still lacking. Whether such a default neural mechanism exist and how this is implemented across a broad spectrum of cell source, is addressed in several studies and still controversially discussed. It was proposed that the default neuronal fate is initiated in the absence of extrinsic signals and is achieved by eliminating extracellular inhibitors of neuroectodermal fate and suppressing cell-cell signalling through limited cell density. Previous studies reported that ESC and ECC grown at low density and in absence of exogenous factors or feeder layers die within 24 h but acquire a neural identity as indicated by expression of the neural marker Nestin. Thus, this application is not suitable for generating neural cultures. Furthermore, it was reported that P19 cells survive and express neuroectodermal marker genes in serum-free DMEM/F12 medium containing transferrin, insulin, and selenite, although no neurites were identified.
Based on this background, in this study, a novel approach to induce neuronal differentiation in vitro was developed that implements a nutrient-poor environment, which, in contrast to previous studies, ensures the survival of neuronally differentiated cells over a long period of time and allows normal formation of neurites. Neither the formation of free-floating aggregates nor supplementation of growth factors or known inducers was required to establish a reliable neuronal differentiation protocol. A simple medium, consisting of DMEM/F12+N2 that was highly diluted in salt solution, was sufficient to drive a fast neuronal differentiation in monolayer cultures. Serum deprivation and strong dilution of DMEM/F12+N2 medium cause a nutrient-poor environment in which the influence of growth factors and inducers is minimized. This medium creates a metabolically defined environment that is presumably free of extrinsic signals that prevent the decision of neuronal fate. Analysis of the medium components discovered no actual inducer. Hence, it was suggested that the metabolic composition of the medium exclusively covers specific cell requirements of neurons, therefore ensures their survival, and drives the switch from pluripotent cells to neurons. The self-developed method was established by usage of the murine embryonal carcinoma cell line P19 and could be transferred to murine ESC. Consequently, the method could provide a feasible protocol for a generally valid neuronal default model.
The established protocol provides several advantages such as the possibility to generate stable pure neuronal cultures by a fast, simple, and highly reproducible one-step induction under defined medium conditions with a minimum of exogen effectors. The method is characterised by clear and steady medium conditions that makes the investigation of specific cell requirements during differentiation accessible. It is therefore expected to be a useful tool to investigate the molecular basis of neuronal differentiation as well as for high throughput screenings. The phenotype of mature postmitotic neurons was arising within one week and cultures were shown to stay stable at least for three weeks. The neuronal identity was confirmed by expression of neuronal markers through immunofluorescence staining and mass spectrometry analysis. Furthermore, increased levels of axon markers were detected in early neuronal differentiation and functionality of the synapses of the P19-derived neurons was ascertained by detection of calcium activity. Axonal laser ablation, immediately followed by fast regrowth of connections in the neuronal network, revealed a strong regeneration potential under the given conditions. Furthermore, the generated neurons showed a morphologically distinct phenotype and the formation of neural rosettes. Immunofluorescence staining demonstrated the generation of pure and homogeneous neuronal cultures, free of glial cells.
Retinoic acid (RA) plays an essential role in cell signalling during embryogenesis and efficiently induces neuronal differentiation in vitro in a concentration dependent manner. Neither retinol nor retinoic acid was included in any of the components of the self-prepared medium in this work. However, I observed, dependence on RARβ- and/or RARγ-regulated RA signalling in serum-free monolayer cultures. Nevertheless, neuronal differentiation in serum-free monolayer cultures was assumed to be RARα-independent because (i) RARα was slightly downregulated after neuronal induction, (ii) the truncated RARα of the RAC65 mutant had no effect on induction efficiency, and (iii) a pan-RAR inhibitor suppressed neuronal differentiation. In contrast to serum-free monolayer cultures, the truncated RARα prevented neuronal differentiation by application of the conventional protocol where cells are grown in free floating cell aggregates in serum-containing medium. Proteome analysis of P19 cells, treated by the self-developed differentiation protocol over five days showed increased levels of cellular RA binding proteins that mediate the cellular RA transport and are involved in canonical as well as non-canonical RA signalling.
...
Even one century after Santiago Ramón y Cajal’s groundbreaking contribu- tions to neuroscience, one of the most fundamental questions in the field is still largely open, namely understanding how the shape of a dendrite is adapted to its specific biological function. A systematic investigation of this problem is challenging both technically and conceptually because neurons have diverse genetic, molecular, morphological, connectional and functional properties.
In the light of the preceding, dendritic arborisation (da) neurons of the Drosophila melanogaster larva PNS have proven to be an excellent model system for the study of such growth and patterning processes. Structure and function in these cell classes are intimately intertwined, as class type-specific dendritic arbour differentiation processes are required to satisfy a given phys- iological need. Also, there is a remarkable genetic toolkit that enables one to selectively and reproducibly label, image and manipulate each one of these sensory neuron classes. In this thesis, I address the aforementioned open problem by linking single-cell patterning, information processing and wiring optimisation in sensory da neurons to behaviour in Drosophila larva.
In particular, I study Class I ventral peripherical dendritic arborisation (c1vpda) neurons. These are a class of proprioceptive neurons that relay information on the position of the larva’s body back to the CNS during crawling behaviour to assure proper locomotion. Their stereotypical comb- like shaped dendritic branches spread along the body-wall, and they get noticeably deformed during crawling behaviour. The bending of the den- dritic branches is hypothesised to be a possible mechanism to transduce the mechanosensory inputs arising from cuticle folding. Interestingly, c1vpda neurons do not necessarily satisfy optimal wiring constraints since they are required to pattern into a specific shape to fulfil their function. Therefore, I considered the da system to study how the specific functional requirements may be combined with optimal wiring constraints during development.
Although the molecular machinery of dendrite patterning in c1vpda neurons is well studied, the precise elaboration of the comb-like shaped dendrites of these cells remains elusive. Moreover, even though a lot of work has been put into the description and quantification of growth processes of the nervous system, there are still few solid and standardised models of arbour staging and patterning. Importantly, the defining parameters that determine the dendrite elaboration program that in turn is responsible for creating the final arbour morphology are still unknown. As a result, unraveling possible universal stages of dendrite elaboration shared between different model systems and cell types is challenging.
Thus, in order to understand the development of the fine regulation of branch outgrowth that leads to the observed terminal arbour morphology in the mature cell, I collected in vivo, long-term, non-invasive high temporal res- olution time-lapse recordings of dendritic trees during the differentiation process in the embryo and its maturation phase in the larva. For further analysis, I developed new algorithms that quantified the structural changes in dendrite morphology in the time-lapse videos. My approach provides a framework to analyse such developmental data, or any dataset comprising continuous morphological dynamical processes in an unbiased way. Using these newly developed methods, I examined the development of a sample of c1vpda cells and identified five stages of differentiation in these data: initial stem polarization, extension, pruning, stabilization, and isometric stretching during larval stages.
The beginning of the growth process is marked by the polarisation of the main stem. Subsequently, during the extension phase, branches emerge interstitially from the existing main stem. Later, higher-order branches sprout from pre-existing lateral branches, increasing arbour complexity. This is followed by a pruning stage where developmental intermediate dendritic branches are removed. This step leads to a spatial rearrangement of the dendritic tree. The end of the pruning step is followed by a stabilisation period where arbour morphology remains virtually unaltered in the embryo. After hatching, c1vpda dendrites experience an isometric scaling, with their branching complexity and pattern being invariant across all larval stages.
After dissecting the c1vpda dendrites spatiotemporal differentiation process, I established a link between dendritic shape and behaviour. I measured intra- cellular Ca++ activity in the dendrite branches of l1 larvae during forward locomotion, while simultaneously recording branch deformation using a dual genetic line. I reported that post-embryonic c1vpda dendrites Ca++ responses increased in freely crawling larvae. Furthermore, I showed strong correlations between Ca++ signal and deformation of the comb-like dendritic ranches during body-wall contractions.
Then, using a geometrical model, I provided evidence that the pruning stage could reorganise the dendrite morphology to maximise mechanosensory re- sponses during body wall contraction. I showed that the angle orientation of each side branch correlates with the bending curvature and thus with the me- chanical displacement of the cell membrane during locomotion. During the pruning phase, I observed a preferential reduction of less efficient branches with low bending curvature, influencing the mechanisms of dendritic sig- nal integration of c1vpda sensory neurons. I proceeded to quantify branch dynamics at single tip resolution during pruning, providing evidence that a simple random pruning mechanism is sufficient to remodel the tree structure compatible with the observed way.
I used these time-lapse data to constrain a new computational noisy growth model with random pruning based on optimal wiring principles. This model is able to generate highly realistic synthetic c1vpda morphologies. The model furthermore requires few parameters to generate highly accurate temporal development trajectories and morphologies at single-cell level. Utilising this data and model enabled me to investigate upon the hypothesis that a noisy dendrite growth and random pruning mechanism synergise to achieve den- dritic trees efficient in terms of both wiring and function. My findings show how single neurons can create functionally specialised dendrites while min- imising wiring costs, elucidating how general principles of self-organisation may be involved in the generation of these structures.
Introduction: The involvement of platelets in various diseases has been increasingly recognized in the recent decades. This contribution is believed to involve platelet secretion and formation of reactive microparticles. Platelets contain two functionally important forms of vesicles, alpha and dense granules, which are secreted upon activation of platelets. Alpha granules incorporate larger molecules such as adhesive proteins, e.g. P-selectin, vWF and fibrinogen; chemokines like PF4 and RANTES and growth hormones like VEGF and PDGF are among the most important proteins attributed to the involvement of platelets in pathological conditions. In contrast, dense granules contain small molecules like ADP, ATP, serotonin and histamine, and they are more rapidly and completely secreted than alpha granules. Like in all secreting cells, regulated exocytosis in platelets is mediated by “zippering” of three different classes of SNARE proteins. The subtypes of these proteins found to be involved in platelet secretion are SNAP-23, syntaxin-2 and -4 and VAMP-3 and -8. Apart from SNARE proteins, other conserved proteins influencing exocytosis by e.g. acting on SNARE proteins have been described, one of the most important ones being Munc13. Platelets contribute to the progression of atherosclerosis by local deposition of inflammatory mediators like PF4, RANTES and CD40L, which leads to enhanced leukocyte recruitment and plaque formation. In 1865, Armand Trousseau first described the correlation between cancer and thrombotic events. Since the 1960s, an increasing number of studies have found an involvement of platelets also in the progression of cancer, especially in the formation of metastases. Platelets bind to circulating tumor cells and may shield them from NK cell attacks and shear stress. Platelets may also facilitate the interaction of tumor cells with other cell types and the vessel wall. Lastly, they may secrete molecules that influence the tumor cell phenotype and invasiveness.
Aims of this study: We sought to generate and describe genetically modified mouse lines with defective platelet secretion and to employ these mouse lines in murine models of atherosclerosis and tumor progression to study the role of platelet secretion under pathological in vivo conditions.
Results: Clostridial toxins cleave members of the SNARE protein family and can thus completely block exocytosis of neuronal and other cells. We generated three transgenic mouse lines expressing tetanus, botulinum-E or -C light chains and two transgenic mouse lines with dominant-negative mutations of SNAP-23 under the control of the platelet-specific PF4 promotor. None of these constructs was able to interfere with platelet secretion despite expression of the transgene. A functional null mutant of the only Munc13 isoform expressed in platelets, Munc13-4, showed complete lack of dense granule secretion, measured by ATP release, while alpha granule release as determined by PF4 and vWF secretion, was unaltered. Morphology, composition and adhesion of these platelets were also normal. Aggregation in response to U46619 and collagen and formation of large aggregates in flow chamber assays was attenuated. Munc13-4-deficient mice showed a severe defect in bleeding time and no formation of stable aggregates in FeCl3 thrombosis model. In response to B16 melanoma and LLC1 carcinoma cells, Munc13-4 KO platelets also showed complete abrogation of dense granule secretion, whereas alpha granule secretion and binding of platelets to tumor cells was unchanged. Interestingly, wild-type platelets, but not Munc13-4 KO platelets, enhanced transmigration of B16 and LLC1 cells through an endothelial cell layer. Exogenous ATP was able to mimic the effect of wild-type platelets and the ATP-degrading enzyme apyrase blocked platelet-mediated tumor cell transmigration. Platelets incubated with tumor cells secreted large amounts of ATP. Murine endothelial cells showed perturbed adherens junctions identified by irregular VE-cadherin staining and gap formation when incubated with supernatants from tumor cell-activated platelets as well as increased permeability under the same conditions. Addition of apyrase preserved normal endothelial morphology and function. In vivo, primary tumor growth and weight was comparable in wild-type and Munc13-4 KO mice upon B16 or LLC1 flank injection but formation of lung metastases was strongly reduced. Number, but not size of metastases was also reduced upon i.v. injection of B16 and LLC1 cells. We found P2Y2 and P2X4 receptors to be the most abundantly expressed endothelial metabotropic and ionotropic ATP receptors, respectively. Neither knock-down nor inhibition of P2X4 in endothelial cells influenced platelet-mediated transendothelial migration of B16 cells, but knock-down of P2Y2, for which no specific antagonist is available, strongly reduced plateletdependent tumor cell transmigration. When B16 melanoma cells were injected i.v. shortly after FITC-dextran (70 kDa) into wild-type mice, prominent leakage of FITC-dextran was observed three hours post-injection at extraluminal sites in the lung. In contrast, leakage into the lung parenchyma was at basal levels in Munc13-4 KO and P2Y2 KO mice after B16 cell injection. Marginal vascular leakage in Munc13-4 KO mice lacking platelet ATP secretion and in P2Y2 KO mice lacking the main endothelial ATP receptor correlated with strongly reduced extravasation of CFSE-labeled B16 melanoma cells 6 hours post-injection in these mice. Consistently, P2Y2 KO mice showed strongly reduced formation of metastases in the lung after i.v. injection of B16 or LLC1 tumor cells. Bone marrow-transplanted LDLR KO mice reconstituted with Munc13-4-deficient or wildtype bone marrow and subjected to 16 weeks of high fat diet showed no significant difference in atherosclerotic plaque formation in the aorta.
Discussion: We hereby provide a thorough analysis of a mouse line with an exclusive defect in platelet dense granule secretion, thus representing a unique genetic tool to study the role of dense granule secretion in various contexts without interfering with other platelet functions. We also provide evidence how extravasation of circulating tumor cells is facilitated by tumor cell-induced ATP release from platelets. This ATP release destabilizes endothelial barriers and facilitates tumor cell extravasation and formation of metastases in the target organ. Since metastasis is the leading cause of cancer death, pharmacological interference with endothelial P2Y2 receptor function may represent a promising therapeutic strategy.
Cardiovascular diseases are still regarded as the main cause of death in the modern world. However, the generic term "cardiovascular diseases" is not uniformly defined. It essentially describes diseases of the cardiovascular system and includes diseases such as hypertension, arteriosclerosis, myocardial infarctions, heart failure, coronary heart diseases, rheumatic heart diseases and heart valve defects. In addition to the well-known risk factors such as obesity, smoking, hypercholesterolemia and lack of exercise, age is a further risk factor that plays an important role in the development of cardiovascular diseases. As the modern societies age; this becomes an increasing problem.
But why does the prevalence of cardiovascular diseases increase with age? In gen-eral, age-dependent changes at the cellular level are assumed to be responsible for the pathological changes in the cardiac and vascular tissues. Important mechanisms such as autophagy, oxidative stress, mitochondrial dysfunctions, genomic instability, cellular senescence and disturbances in signaling pathways of growth factors play a decisive role. In old age, myocardial hypertrophy occurs, which results in cardiac wall thickening and an altered geometry of the ventricle. Chronic inflammations, paracrine and age-dependent cell-intrinsic factors further lead to activation of cardiac fibro-blasts with increase cell proliferation, collagen secretion and matrix cross-linking. The consequences are interstitial and perivascular fibrosis, which stiffen the heart and blood vessels. Oxidative stress and inflammations additionally attack the blood ves-sels and impair endothelial function, which is further aggravated by possible pre-existing conditions such as diabetes mellitus and hypertension.
In the past decades, the main focus has therefore been on researching these age-dependent changes in the hope of better understanding cardiovascular ageing and developing possible regenerative interventions. By studying the repair mechanisms of other organs such as the lungs and the bone marrow, the endothelium in particular showed a high regenerative capacity, which influences the proliferation and cell func-tion of the surrounding cells.
For a long time, the general opinion was that the endothelium is only the internal lin-ing of blood and lymphatic vessels, as well as the heart chambers, which as a single-layer barrier guarantees the integrity of the blood vessels. However, endothelial cells are very heterogeneous, depending on the type of blood vessel and the type of tis-sue they serve. In addition to their barrier function, endothelial cells also regulate the exchange of substances between blood and tissue, stimulate the formation of new blood vessels and re-model existing vascular networks. They are also able to re-structure the extracellular matrix that surrounds them. They release not only matrix proteins, but also cytokines and growth factors into the extracellular space. On de-mand, these factors are then released and stimulate angiogenesis or cell prolifera-tion. In addition, the secretion of various matrix proteins not only stabilizes the cellu-lar neighborhood, but also regulates various cell functions.
By modelling the endothelial environment - the so-called vascular niche - endothelial cells are able to communicate with the surrounding cells. As a result, a regenerative effect of the vascular niche has already been described in various organs. In the liv-er, for example, it has been shown that increased concentrations of endothelial Ang2 and decreased endothelial activin A after partial hepatectomy stimulate the prolifera-tion of hepatocytes and thus liver regeneration. In the bone marrow, endothelial cells mobilize stem cells via nitric oxide and in the lungs, endothelial MMP14 releases growth factors from the extracellular matrix, which stimulate epithelial cell prolifera-tion after partial pneumectomy. Whether such a regenerative effect of the vascular niche also plays a role in the heart is largely unknown.
Since both the regenerative capacity of the heart and endothelial function decrease with age, the aim of this dissertation was to investigate the role of the vascular niche and endothelial cell communication in the aged heart. Human cell lines as well as mouse and artificial rat models were used for these investigations. Since this thesis is a cumulative dissertation with partially published papers, it is divided into three parts.
In the first part of this thesis, the transcriptional signature of secretory genes in the aged cardiac endothelium was studied. Perfused endothelial cells from hearts of young (12-week-old animals) and old mice (20-month-old animals) were isolated and used for bulk RNA sequencing. The two matrix proteins laminin β1 and β2 were among the top-regulated genes. While laminin β2 was particularly expressed in the young cardiac endothelium, laminin β1 was predominantly found in the old endotheli-um. This change in laminin expression was confirmed histologically at protein level and its autocrine function was investigated in vitro. To mimic the in vivo situation in vitro, cell culture dishes were coated with human recombinant laminin 421 or laminin 411 and sutured with human endothelial cells from the umbilical vein (HUVEC). Di-verse functional investigations showed that endothelial cells migrated and adhered poorly in the presence of laminin 411, while in Matrigel tube formation assays HU-VEC formed reduced endothelial networks when cultured on LM 411.
...
Cardiovascular disease is the leading cause of death worldwide. Aging is among the greatest risk factors for cardiovascular disease. Cardiovascular disease comprises several diseases, for example myocardial infarction, elevated blood pressure and stroke. Many processes are known to promote or worsen cardiovascular disease and in the present study, cellular senescence and inflammatory activation were of special interest, as they have a strong association to aging and can be seen as hallmarks of cellular aging.
Long noncoding RNAs (lncRNAs) are noncoding RNAs with a length of more than 200 nucleotides. In recent years, numerous regulatory functions were shown for these transcripts and lncRNAs were shown to directly interact with DNA, RNA and proteins. The long noncoding RNA H19 was among the first described noncoding RNAs and was initially shown to act as a tumor suppressor. More recently, several studies showed oncogenic roles for H19. In regards to the cardiovascular system, H19 was not analyzed before.
We show that H19 is the most profoundly downregulated lncRNA in endothelial cells of aged mice compared to young littermates. Microarray analysis of human primary endothelial cells upon pharmacological H19 depletion revealed an involvement of H19 in cell cycle regulation. Loss of H19 in human endothelial cells in vitro led to reduced proliferation and to increased senescence. H19 depletion was shown to counteract proliferation before, but none of the described mechanisms applied to endothelial cells. We show that the reduction in proliferative capacity and the pro-senescent function of H19 is most probably mediated by an upregulation of p16ink4A and p21 upon H19 depletion.
When we compared the angiogenic capacity of aortic endothelial cells from young and aged mice in an aortic ring assay, rings from aged mice showed a reduced cumulative sprout length. Interestingly, pharmacological inhibition of H19 in aortic rings of young animals, where H19 is highly expressed, was sufficient to reduce the cumulative sprout length to levels we observed from aged animals. Furthermore, overexpression of human H19 in aortic rings of aged mice, where H19 is poorly expressed, rescued the impaired angiogenic capacity of aged endothelial cells.
We generated inducible endothelial-specific H19 knockout mice (H19iEC-KO) and subjected these animals to hind limb ischemia surgery followed by perfusion analysis in the hind limbs by laser-doppler velocimetry and histological analysis. Perfusion in the operated hind limb was increased in H19iEC-KO compared to Ctrl littermates, which was in contrast to a reduction in capillary density in the operated hind limbs of H19iEC-KO animals compared to Ctrl littermates and to our previous results. Analysis of arteriogenesis revealed an increase in collateral growth upon EC-specific H19 depletion in the ischemic hind limbs, which explains the increase in perfusion despite the reduction in capillary density. Further characterization of the animals revealed an increase in leukocyte infiltration into the tissue in the ischemic hind limbs upon endothelial-specific H19 depletion, indicating a potential role of H19 in inflammatory tissue activation.
Reanalysis of the microarray data from human primary endothelial cells upon H19 depletion revealed an association of H19 with inflammatory signaling and more specifically with IL-6/JAK2/STAT3 signaling. Analysis of cell surface adhesion molecule expression revealed an upregulation of ICAM-1 and VCAM-1 on mRNA level and an increase of the abundance of the two proteins on the cell surface of human primary endothelial cells. Consequently, adhesion of isolated human monocytes to human primary endothelial cells was increased upon H19 depletion in vitro. Interestingly, TNF-α mediated inflammatory activation of primary human endothelial cells repressed H19 expression. H19 did not function via previously described mechanisms. We excluded a competitive endogenous RNA (ceRNA) function for H19 in endothelial cells and showed that miR-675, which is processed from H19, does not play a role in the endothelium. Furthermore, H19 did not regulate previously described genes or pathways.
Analysis of transcription factor activity upon H19 depletion and overexpression revealed a differential activity of STAT3. STAT3 phosphorylation at TYR705 and thus activation was increased upon H19 depletion. Inhibition of STAT3 activation using a small compound inhibitor abolished the effects of H19 depletion on mRNA expression of p21, ICAM-1 and VCAM-1 and on proliferation, indicating that the effects of H19 are at least partially mediated via STAT3. STAT3 was shown to have positive effects on the cardiovascular system before, most likely due to upregulation of VEGF in a STAT3-dependent manner. We were not able to confirm previously described mechanisms for STAT3 in the present study and propose a new mechanism of action for the H19-dependent regulation of STAT3. Taken together, these results identify the long noncoding RNA H19 as a pivotal regulator of endothelial cell function. Figure 38 summarizes the described functions of H19 in endothelial cells.
Flow hemodynamics regulates endothelial cell (EC) responses and laminar shear stress induces an atheroprotective and quiescent phenotype. The flow-responsive transcription factor KLF2 is a pivotal mediator of endothelial quiescence, but the precise mechanism is unclear. In this doctoral study, we assessed the hypothesis that laminar shear stress and KLF2 regulate endothelial quiescence by controlling endothelial metabolism.
Laminar flow exposure and KLF2 over expression in HUVECs reduced glucose uptake. Endothelial specific deletion of KLF2 (EC-KO) in mice and subsequent infusion of labeled glucose in Langendorff perfused hearts induced glucose uptake in ECs lacking KLF2. Bioenergetic measurements revealed that KLF2 reduces and glycolytic acidification in vitro.
Mechanistically, RNA sequencing analysis of shear stimulated ECs showed reduced expression of key glycolytic enzymes Hexokinase 2, PFKFB3 and PFK-1. KLF2 also reduced expression of these enzymes at protein level. KLF2 knockdown in shear stimulated ECs reversed the reduction in expression of PFKFB3 and PFK-1, indicating KLF2-dependency. Promoter analysis revealed KLF binding sites in the promoter of PFKFB3 and KLF2 over expression markedly reduced PFKFB3 promoter activity which was abolished on mutation of the KLF binding site. In addition, PFKFB3 knockdown reduced glycolysis while over expression increased glycolysis. Over expression of PFKFB3 along with KLF2 partially reversed the KLF2-mediated reduction in glycolysis. Importantly, PFKFB3 over expression reversed KLF2-mediated reduction in angiogenic sprouting and network formation in vitro. Ex-vivo aortic ring assays revealed an increase in endothelial sprouting from aortas from KLF2 EC-KO mice, which was partially reversed upon PFKFB3 inhibition by 3-PO.
In conclusion, work performed during this doctoral thesis demonstrates that laminar shear stress and KLF2 mediated repression of endothelial metabolism via regulation of PFKFB3 contributes to the anti-angiogenic and quiescent properties of the endothelium.
Cerebellar ataxias are a group of neurodegenerative disorders primarily affecting the cerebellum. Although causative mutations in several genes have been identified there is currently no cure for ataxias.
The first part of this dissertation is focused on Spinocerebellar ataxia type 2 (SCA2). SCA2 is a dominant ataxia caused by repeat expansion mutations in the ATXN2 gene, which encodes the protein Ataxin2 (ATXN2). A polyglutamine (polyQ) tract consisting of CAG repeats interrupted by CAA was identified at exon 1 of ATXN2. Healthy individuals have between 22 and 23 glutamines, while expansions longer than 33 CAG repeats cause SCA2. The most noticeable symptom that SCA2 patients show is ataxic gait; however, they also show cerebellar dysarthria, dysdiadochokinesia, and ocular dysmetria caused by the progressive cerebellar degeneration.
To model the SCA2 disease, we generated a new mouse model where 100 CAG repeats were introduced in the mouse Atxn2 gene via homologous recombination. The characterization of this mouse model, Atxn2-CAG100-KIN, demonstrated that it reproduces the symptomatology observed in SCA2 patients. These animals showed significant loss of weight over time, brain atrophy, and motor deficits.
In addition, ATXN2 intermediate expansions have been linked to the pathology of Amyotrophic lateral sclerosis (ALS) as a risk factor. ALS is a fatal neurodegenerative disease where the motor neurons in the brain and spinal cord degenerate. A hallmark of ALS is the presence of TDP43-positive inclusions in neurons and glia. Further studies of post mortem spinal cord samples from SCA2 patients showed severe and widespread neurodegeneration of the central somatosensory system. Therefore, it was of interest to further investigate the pathology affection of this tissue in the Atxn2-CAG100-KIN line and the relationship between ATXN2 and TDP43. The characterization of the spinal cord pathology via protein quantification, transcript quantification, and immunohistochemistry showed a preferential affection of RNA binding proteins (RBP) in the spinal cord rather than the cerebellum. The ALS-linked factors TDP43 and TIA1 showed time-dependent co-aggregation with ATXN2 in spinal cord sections together with an increase of CASP3 levels. Therefore, this mouse model can help develop new therapies and evaluate their effect in differently affected areas.
A transcriptome data set from Atxn2-CAG100-KIN spinal cord samples at the final disease stage of this mouse model showed a strong up-regulation of RNA toxicity-, immune- and lysosome-implicated factors. These data pointed to a pathological reactivation of the synaptic pruning and phagocytosis in microglia. ATXN2-positive aggregates were found in microglia from spinal cord sections of 14-month-old Atxn2-CAG100-KIN via immunohistochemistry. The characterization of microglial response and the potentially deleterious effects of the expanded ATXN2 in this cell type could lead to therapies to improve patients’ living standards or delay the symptoms’ onset.
The second part of this thesis was focused on an autosomal recessive form of cerebellar ataxia, Ataxia Telangiectasia (A-T), with childhood onset. A-T patients show severe cerebellar atrophy manifesting as ataxia when the child starts to walk. The genetic cause of A-T is loss-of-function-mutations in the Ataxia Telangiectasia Mutated gene (ATM). ATM is a kinase involved in DNA damage response, oxidative stress, insulin resistance, autophagy via mTOR signaling, and synaptic function.
Working with proteome data from cerebrospinal fluid of 12 A-T patients and 12 healthy controls, we aimed to define novel biomarkers that would allow following the neurodegeneration in extracellular fluid. Additional validation efforts with ~2-month-old Atm-knock-out (Atm-/-) cerebellar samples helped us to define a scenario were the deficit of vesicle-associated ATM alters the secretion of ApoB, reelin, and glutamate. As extracellular factors, apolipoproteins and their cargo such as vitamin E may be useful for neuroprotective interventions.
Bei Autismus-Spektrum-Störungen (ASS) handelt es sich um genetisch komplexe Störungen mit hoher Erblichkeit. Als zugrundeliegender Pathomechanismus von ASS werden unter anderem Veränderungen der neuronalen Entwicklung diskutiert. Der Phänotyp von ASS ist definiert durch Einschränkungen in der sozialen Interaktion und Kommunikation sowie repetitives und stereotypes Verhalten. Genkopiepolymorphismen (englisch „copy number variations“/CNVs), also Deletionen oder Duplikationen einer chromosomalen Region, wurden wiederholt in Probanden mit ASS identifiziert. Hierbei ist in ASS die Region 16p11.2 mit am häufigsten von CNVs betroffen. Einige Gene aus diesem chromosomalen Abschnitt wurden bereits funktionell charakterisiert. Dennoch können die Befunde der bisherigen Einzelgenstudien nicht alle Aspekte erklären, die durch 16p11.2 CNVs hervorgerufen werden. Ziel dieser Studie war es daher, ein weiteres neuronal assoziiertes Kandidatengen dieser Region zu identifizieren und im Anschluss funktionell im Kontext der neuronalen Differenzierung zu charakterisieren.
Das SH-SY5Y Neuroblastom-Zellmodell wurde auf Transkriptom- und morphologischer Ebene auf seine Eignung als Modell für neuronale Differenzierung untersucht und bestätigt. Eine Analyse der Expressionen aller Gene der 16p11.2-Region zeigte, dass das Gen Quinolinat-Phosphoribosyltransferase (QPRT) eine vergleichsweise hohe Expression mit der stärksten und robustesten Regulierung über die Zeit aufwies. Eine de novo Deletion der 16p11.2-Region wurde in einem Patienten im Vergleich zu seinen Eltern validiert. In Patienten-spezifischen lymphoblastoiden Zelllinien derselben Familie konnten wir eine Gendosis-abhängige Expression von QPRT auf RNA-Ebene bestätigen. In SH-SY5Y-Zellen korrelierte die Expression von QPRT signifikant mit der Entwicklung von Neuriten während der Differenzierung. Um QPRT funktionell zu charakterisieren, benutzten wir drei verschiedene Methoden zur Reduktion der QPRT-Gendosis: (i) knock down (KD) durch siRNA, (ii) chemische Inhibition durch Phthalsäure und (iii) knock out (KO) über CRISPR/Cas9-Geneditierung. Eine Reduktion von QPRT durch siRNA führte zu einer schwachen Veränderung der neuronalen Morphologie differenzierter SH-SY5Y-Zellen. Die chemische Inhibition sowie der genetische KO von QPRT waren letal für differenzierende aber nicht für proliferierende Zellen. Eine Metabolitenanalyse zeigte keine Veränderungen des QPRT-assoziierten Tryptophanstoffwechsels. Gene, welche auf Transkriptomebene im Vergleich zwischen KO- und Kontrollzellen differenziell reguliert vorlagen, waren häufig an Prozessen der neuronalen Entwicklung sowie an der Bildung, Stabilität und Funktion synaptischer Strukturen beteiligt. Die Liste differenziell regulierter Gene enthielt außerdem überdurchschnittlich viele ASS-Risikogene und ko-regulierte Gengruppen waren assoziiert mit der Entwicklung des dorsolateralen präfrontalen Cortex, des Hippocampus sowie der Amygdala.
In dieser Studie zeigten wir einen kausalen Zusammenhang zwischen QPRT und der neuronalen Differenzierung in vitro sowie einen Einfluss von QPRT auf die Regulation von ASS-assoziierten Genen und Gen-Netzwerken. Funktionell standen diese Gene im Kontext mit synaptischen Vorgängen, welche durch Veränderungen zu einem Exzitations-Inhibitions-Ungleichgewicht und letztendlich zum Zelltod von Neuronen führen können. Unsere Ergebnisse heben in Summe die wichtige Rolle von QPRT in der Krankheitsentstehung von ASS, insbesondere in Trägern einer 16p11.2 Deletion, hervor.
Der Neocortex der Säugetiere weist charakteristische Schichtungen auf, und jede dieser Schichten enthält verschiedene Typen von Neuronen, die in stereotypen Mustern angeordnet sind. Die Ausbildung dieser geschichteten Struktur ist nur dann möglich, wenn korrekte Migration von Neuronen von proliferativen Zonen zu deren Endpositionen stattfindet. Die exakte Migration und Schichtung wird von Mutationen beeinflusst, die entweder die migratorische Fähigkeit der Neuronen beeinträchtigen, oder deren Fähigkeit, die Position zu erkennen, an der sie die Wanderung beenden sollten (Gupta et al., 2002, Rice et al., 2001, Walsh et al., 2000). In den letzten Jahren wurde das extrazelluläre Protein Reelin als wichtiger Faktor bekannt, der sich auf mehrere Schritte der neuronalen Migration und Schichtung in der Großhirnrinde auswirkt (zusammengefasst in (Tissir et al., 2003). Das sekretierte Glykoprotein Reelin kontrolliert die Migration der Neuronen durch die Bindung an zwei Lipoproteinrezeptoren, den Very-low-density lipoprotein Rezeptor (VLDLR) und den Apolipoprotein E Rezeptor 2 (ApoER2) (D'Arcangelo et al., 1999). Die Bindung von Reelin an ApoER2 und VLDLR ruft die Phosphorylierung von Disabled-1 (Dab1) (D'Arcangelo et al., 1999, Howell et al., 1997), einem Adapterprotein, das an die intrazelluläre Domäne der Rezeptoren bindet, hervor, indem sie Kinasen der Src-Familie (SFKs) aktiviert (Arnaud et al., 2003, Bock et al., 2003a). Außer der Bedeutung des Reelin-Signalwegs für die korrekte Entwicklung des Nervensystems und dem Wissen, dass die Unterbrechung dieses Signalwegs zu verschiedenen neurologischen Krankheiten wie Epilepsie, Schizophrenie und der Alzheimerkrankheit führt (Costa et al., 2002, Botella-Lopez et al., 2006, Herz et al., 2006), ist die molekulare Grundlage der Aktivierung dieses Signalwegs an der Zellmembran noch kaum charakterisiert. Da VLDLR und ApoER2 keine intrinsische Kinaseaktivität besitzen, wurde die Existenz eines Korezeptors für mindestens eine Dekade vermutet, und die genaue Natur dieses Korezeptors ist unbekannt. EphrinBs, Transmembranliganden für Eph-Rezeptoren, besitzen die Fähigkeit zur Signalgebung, die für synaptische Plastizität und Angiogenese durch Sprossung erforderlich ist, indem sie die Aktivität anderer Transmembranrezeptoren wie AMPAR beziehungsweise VEGFR2 beeinflussen (Sawamiphak et al., 2010b, Segura et al., 2007, Essmann et al., 2008). Darüber hinaus führt die Stimulation von cortikalen Neuronen in Kultur mit löslichen EphB-Rezeptoren zur Rekrutierung und Aktivierung von SFKs in Membranpatches, in denen sich ephrinB-Liganden befinden (Palmer et al., 2002). Deshalb nehmen wir an, dass ephrinB in vivo funktionell mit dem Reelin-Signalweg verbunden sein könnte. Der Fokus dieser Arbeit liegt darin, zu zeigen, dass das neuronale Wegweisermolekül ephrinB einen entscheidenden Korezeptor für die Reelin-Signalgebung während der Entwicklung geschichteter Strukturen im Gehirn darstellt. Um zu erforschen, ob ephrinB und die Reelin-Signalgebung in vivo genetisch interagieren, wurden zuerst Mäuse mit Compound-Mutationen hergestellt, die eine Nullmutation im Gen für ephrinB3 tragen und heterozygot für Reelin sind (rl/+; b3-/-). Reeler ist eine autosomal rezessive Mutation der Maus, die, wenn sie heterozygot auftritt, keinen offenkundigen Phänotyp aufweist (Caviness et al., 1972, Caviness et al., 1978). Wir zeigen, dass ephrinBs genetisch mit Reelin interagieren, da Mäuse mit Compound-Mutationen (rl/+; b3 -/-) und ephrinB1-, B2- und B3-Dreifach-Knockouts die verschiedenen Defekte in der Entwicklung phänokopieren, die im Neocortex, Hippocampus und Cerebellum der reeler-Mäuse beobachtet wurden. Eines der Kennzeichen des reeler-Phänotyps ist die gestörte Schichtung der Großhirnrinde mit einer Marginalzone (MZ), die eine äußerst große Zahl an Zellen enthält (Caviness, 1982). Sowohl die Compound-Mäuse als auch die Triple-ephrinB1B2B3-knockouts zeigten eine Zunahme der Zellzahl in der MZ. Um die cortikalen Defekte detailliert zu charakterisieren, wurde die Verteilung von postmitotischen migrierenden Neuronen im Cortex von rl/+; b3-/- Compound-Mäusen mit Hilfe von unterschiedlichen schichtenspezifischen Markern für früh (Tbr1) (Hevner et al., 2001) und spät entstandene (SatB2 and Brn1) (Britanova et al., 2008, McEvilly et al., 2002) Neuronen, analysiert . Unsere Untersuchungen ließen die veränderte cortikale Schichtung in den rl/+; b3-/- Compound-Mäusen erkennen. So befanden sich früh entstandene Neuronen in den oberen cortikalen Schichten und spät entstandene in den unteren cortikalen Schichten, was für eine outside-in-Schichtung spricht, wie man sie von reeler kennt. Interessanterweise ist eine der frühesten strukturellen Abnormalitäten, die man im reeler-Cortex erkennen kann, die Unfähigkeit, die Preplate, die reich an extrazellulärer Matrix ist, in die Marginalzone und die Subplate aufzuspalten (Sheppard et al., 1997). Zum Zeitpunkt E17.5 zeigten rl/+; b3-/- Compound-Mäuse eine beachtliche Anhäufung von Chondroitin-Sulfat-Proteoglykan (CSPG), einer Komponente der extrazellulären Matrix, im gesamten Neocortex mit einer ungeteilten Schicht an der Oberfläche, welche übermäßig viel CSPG enthielt und somit die abnorme Teilung der Preplate der reeler-Maus nachahmte. Um zu bestätigen, dass die beobachteten Effekte auf die Schichtung des Cortex der rl/+; b3-/- Compound-Mäuse als Folge der Beeinträchtigung der neuronalen Migration auftritt, wurden zusätzlich BrdU-Puls-Experimente durchgeführt. BrdU wird in sich teilende Vorläuferzellen eingebaut und spiegelt deshalb das migratorische Verhalten von neu entstandenen Neuronen zum Zeitpunkt der Injektion wieder. Schwangeren Weibchen wurde BrdU zu den Zeitpunkten E12.5, E15.5 und E17.5 injiziert und die Gehirne wurden am postnatalen Tag 20 ausgewertet. Die Verteilung der mit BrdU gekennzeichneten Neuronen zu verschiedenen Zeitpunkten der Entwicklung in der Großhirnrinde bestätigte unsere Untersuchungen, die mit Hilfe der schichtspezifischen Marker durchgeführt worden waren. Deshalb deuten unsere Ergebnisse an, dass die beobachteten Defekte in der Schichtung des Cortex tatsächlich eine Folge von beeinträchtigter neuronaler Migration sind. Es wurde beobachtet, dass auch geschichtete Strukturen im Hippocampus in den rl/+; b3-/- Compound-Mäusen verändert sind, was für einen Crosstalk zwischen ephrinB3 und Reelin auch während der Entwicklung des Hippocampus spricht. Die CA1-Region des Hippocampus zeigte eine lockere Verbindung der pyramidalen Zellschichten, welche zu einer signifikanten Erhöhung der Dicke dieser Region und zu einer Einwanderung von Pyramidalzellen in das Stratum oriens führte. Darüber hinaus haben die Anomalien in den dendritischen Verzweigungen von Pyramidalneuronen der CA1-Region, die in Richtung der Reelin-produzierenden Cajal-Retzius-Zellen im stratum locunosum moleculare projizieren, in den rl/+; b3-/- Compound-Mäusen eine auffallende Ähnlichkeit mit denen, die in reeler-Mutanten beobachtet wurden. Reelin fungiert auch als Differenzierungsfaktor und Positionierungssignal für radiale Gliazellen, die positiv für glial fibrillary acidic protein (GFAP) sind und ein Gerüst für die korrekte Migration von neu entstandenen Granularzellen, die auf das Netzwerk der Granularzellen im Gyrus dentatus zuwandern (Forster et al., 2002) bilden. In rl/+; b3-/- Compound-Mäusen ist dieses Gerüst aus radialen Gliazellen schwerwiegend beeinträchtigt, was ebenfalls zu einer lockeren Organisation der Granularzellen im Gyrus dentatus führt. Die Ataxie in reeler-Mäusen ist das Ergebnis einer schwerwiegenden Fehlorganisation im Cerebellum dieser Mutanten (Tissir et al., 2003). Interessanterweise wurden nur milde Defekte in den Granularzellen, die sich in der internen Granularschicht des Cerebellums von rl/+; b3-/- Compound-Mäusen angesammelt haben, und keine Defekte in der Migration und der Verzweigung der Purkinjezellschicht, festgestellt. Stattdessen ist ephrinB2 in den Purkinjezellen des Cerebellums stark exprimiert (Liebl et al., 2003) und obwohl keine bedeutenden Defekte der Migration dieser Zellen festgestellt wurden, zeigte die Untersuchung der Verzweigung der Purkinjezellen in b2-/- Mäusen eindeutige Defekte, die bereits in einfachen ephrinB2-Mutanten auftraten. Bedeutend ist, dass die Defekte in der Verzweigung bei rl/+; b2-/- Compound-Mäusen signifikant verstärkt waren, was darauf hindeutet, dass der Reelin-Signalweg im Cerebellum spezifisch ephrinB2 benötigt. Um Einblicke in den Mechanismus zu erhalten, wie ephrinB-Liganden den Crosstalk mit Reelin durchführen, um die korrekte Positionierung von Neuronen in den geschichteten Strukturen des Gehirns zu kontrollieren, wurde als nächstes die biochemische Interaktion dieser beiden Signalwege untersucht. In einer gerichteten proteomischen Untersuchung mit Hilfe der Tandem affinity purification-mass spectometry-Methode (Angrand et al., 2006) von Proteinen aus eine Neuroblastom-Zelllinie, die ephrinB binden, wurde Reelin als ein Protein, das mutmaßlich mit ephrinB interagiert, identifiziert. Zunächst bestätigten wir die Fähigkeit von Reelin, mit ephrinBs zu assoziieren mit Ko-Immunpräzipitation beider endogener Proteine aus Gehirnlysaten. Das extrazelluläre Protein Reelin zeigte eine starke Bindung an die extrazelluläre Domäne von ephrinB3 und auch von ephrinB2, was andeutet, dass beide ephrin-Liganden die Funktionen von Reelin in vivo beeinflussen könnten. Die Stimulierung von cortikalen Neuronen mit Reelin führt zu einer effektiven Tyrosin-Phosphorylierung des Adapters Dab1. Da die Stimulation von cortikalen Neuronen mit einer löslichen, vorgeclusterten Form von EphB-Rezeptoren zur Rekrutierung und Aktivierung von Src-Kinasen in ephrinB-Clustern führt (Palmer et al., 2002), nehmen wir an, dass ephrinBs Src-Kinasen in VLDLR- und ApoER2-Rezeptor-Clustern rekrutieren und aktivieren könnten. Aktivierte Src-Kinasen phosphorylieren dann wiederum das Adapterprotein Dab1, das an VLDLR und ApoER2 gebunden ist und initiieren die weitere Signalgebung. In Übereinstimmung damit ko-immunpräzipitiert phosphoryliertes Dab1 zum Zeitpunkt E16.5 mit ephrinBs, während die neuronale Migration und die Schichtung des Cortex stattfindet. Darüber hinaus konnten wir beobachten, dass ephrinB3, das durch EphB3-Fc aktiviert wurde, sowohl Reelin, als auch ApoER2 und VLDLR in ephrinB3-Membranpatches in cortikalen Neuronen anhäuft. Die Aktivierung von ephrinB-Liganden durch Stimulation von cortikalen Neuronen mit EphB3-Fc führt zur Rekrutierung und Phosphorylierung von Dab1 in ephrinB-Clustern. Als nächstes befassten wir uns mit der Notwendigkeit von der durch ephrinB vermittelten Rekrutierung und Aktivierung von Src-Kinasen für den Reelin-Signalweg, indem wir Loss-of-function-Studien sowohl in cortikalen Neuronen in Kultur als auch in vivo in Mäusen durchführten. Cortikale Neuronen, die aus ephrinB3- und ephrinB2-Knockouts isoliert wurden, zeigten eine signifikante Beeinträchtigung der durch Reelin vermittelten Phosphorylierung von Dab1 und die Phosphorylierungslevels von Dab1 in ephrinB3 Mausmutanten waren stark verringert, was andeutet, dass ephrinBs Korezeptoren, die notwendig für einwandfreie Signalgebung durch Reelin sind, darstellen. Um die Bedeutung von ephrinBs für die Kontrolle der Funktion von Reelin zu untersuchen, arrangierten wir eine Reihe von Rescue-Experimenten sowohl in Neuronenkulturen als auch während der neuronalen Migration im Cortex in vivo. Aus reeler-Mäusen isolierte cortikale Neuronen zeigten die erwartet verringerte Phosphorylierung von Dab1, die rückgängig gemacht werden konnte, indem die Neuronen mit exogenem Reelin stimuliert wurden. Noch bedeutender ist die Tatsache, dass die Phosphorylierung von Dab1 durch die alleinige Aktivierung von ephrinBs mit EphB wiederhergestellt werden konnte, was die Bedeutung der ephrinBs als Korezeptoren für die Aktivierung des Signalwegs über die Rezeptoren für Reelin, VLDLR und ApoER2, wiederspiegelt. Um die Rolle von ephrinBs als Korezeptoren für den Reelin-Signalweg während der neuronalen Migration in der Großhirnrinde zu unterstreichen, setzten wir ähnliche Rescue-Experimente in organotypischen Schnittkulturen an. In den Schnitten von reeler-Mäusen und Wildtyp-Wurfgeschwistern wurde die Migration von Neuronen, die durch Fc als Kontrolle und EphB3-Fc stimuliert wurde, nach drei Tagen in Kultur untersucht. Die reeler-Schnitte zeigten den typischen reeler-Phänotyp in der Großhirnrinde. In Übereinstimmung mit der Annahme einer wirksamen Regulation des Reelin-Signalwegs war die Aktivierung von eprhinB mit EphB-Rezeptoren in der Lage, die migratorischen Defekte in reeler-Schnitten aufzuheben. Zusammengefasst identifizieren unsere Ergebnisse ephrinBs als Korezeptoren für den Reelin-Signalweg, die für die Funktion von Reelin in der neuronalen Migration während der Entwicklung der geschichteten Strukturen der Großhirnrinde, dem Hippocampus und dem Cerebellum notwendig sind. Unsere genetischen Analysen von ephrinB-Mutanten zeigen gemeinsam mit starken biochemischen Untersuchungen, dass ephrinBs in vivo für zahlreiche Aktivitäten von Reelin erforderlich sind.
Die Analyse früher Entwicklungsstadien von Säugetierembryonen und daraus gewonnener Stammzelllinien kann entscheidende Erkenntnisse im Bereich der Reproduktionsbiologie und der regenerativen Medizin hervorbringen. Dabei spielt die Maus, als geeignetes Modellsystem für die Übertragbarkeit auf den Menschen eine wichtige Rolle, in erster Linie weil die Blastozysten der Maus verglichen mit menschliche Blastozysten eine morphologische Ähnlichkeit aufweisen. Humane embryonale Stammzelllinien haben großes Potential für die Anwendung in der regenerativen Medizin und vergleichend dazu wurde Gen-Targeting in embryonalen Stammzellen verwendet, um tausende neuer Mausstämme zu generieren. Die Gewinnung embryonaler Stammzellen erfolgt im Blastozystenstadium, diese können dann nach Injektion in eine andere Blastozyste zur Entwicklung aller Gewebearten, einschließlich der Keimbahngewebe, beitragen (Martin, 1981; Evans and Kaufman 1981).
Ursache einer Fehlgeburt können vor allem Defekte in der Entwicklung des Trophoblasten und des primitive Entoderms (PrE) sein, dabei sind ca. 5 % der Paare betroffen die versuchen ein Kind zu bekommen (Stephenson and Kutteh, 2007). Eine Untersuchung dieser Zelllinien im Mausmodell könnte weitere Erkenntnisse für die Gründe einer Fehlentwicklung liefern. Trophoblasten Stammzelllinien können aus den Blastozysten der Maus und dem extraembryonalen Ektoderm von bereits implantieren Embryonen gewonnen werden (Tanaka et al., 1998). Diese Zelllinien geben Aufschluss über die Entwicklung des Trophoblasten, fördern die Entwicklung der Plazenta und sind gleichzeitig ein gutes Modellsystem um die Implantation des Embryos im Uterus näher zu untersuchen. Zellen des primitive Entoderms (PrE) beeinflussen das im Dottersack vorhandene extraembryonale Entoderm, welches dort als “frühe Plazenta” fungiert und für die Versorgung des Embryos mit Nährstoffen zuständig ist (Cross et al., 1994). Des Weiteren besitzt das Entoderm einen induktiven Einfluss auf die Bildung von anterioren Strukturen und die Bildung von Endothelzellen sowie Blutinseln (Byrd et al., 2002).
Extraembryonale Endodermstammzellen (XEN Zellen) können aus Blastozysten gewonnen und in embryonale Stammzellen (ES-Zellen) umgewandelt werden (Fujikura et al., 2002; Kunath et al., 2005). Es war jedoch nicht bekannt, ob XEN-Zellen auch aus Postimplantations-Embryonen gewonnen werden können. XEN-Zellen tragen in vivo zur Entwicklung des Darmendoderms bei (Kwon et al., 2008; Viotti et al., 2014) und könnten als alternative, selbsterneuernde Quelle für extraembryonale Endoderm-abgeleitete Zellen dienen, die zur Herstellung von Geweben für die regenerative Medizin verwendet werden könnten (Niakan et al., 2013).
In der Embryogenese der Maus zeigt sich an Tag E3.0 eine kompakte Morula die sich allmählich in das Trophektoderm (TE) differenziert, welches wiederum den Embryonalknoten (“innere Zellmasse”) umschließt (Johnson and Ziomek, 1981). Ein wichtiger Schritt im Rahmen der Entwicklung findet an Tag E3.5 statt, in diesem Zeitraum gehen aus dem Embryonalknoten der pluripotente Epiblast und das primitive Entoderm hervor. Im späten Blastozystenstadium an Tag E4.5 liegt das PrE als Zellschicht entlang der Oberfläche der Blastocoel-Höhle. Aus dem Epiblast entwickeln sich im weiteren Verlauf der Embryo, das Amnion und das extraembryonale Mesoderm des Dottersacks. Die Zellen des Trophektoderm führen zur Entwicklung der Plazenta. Das PrE differenziert sich im Zuge der Weiterentwicklung in das viszerale Entoderm (VE) und das parietale Entoderm (PE) des Dottersacks (Chazaud et al., 2006; Gardner and Rossant, 1979; Plusa et al., 2008). VE umgibt den Epiblast und extraembryonisches Ektoderm (ExE). PE-Zellen wandern entlang der inneren Oberfläche von TE und sezernieren zusammen mit Trophoblasten-Riesenzellen Basalmembranproteine, um die Reichert-Membran zu bilden (Hogan et al., 1980). Die Reichert-Membran besteht aus Basalmembranproteinen, einschließlich Kollagenen und Lamininen, die zwischen den parietalen Endoderm- und Trophoblastzellen liegen. Diese Membran wirkt als ein Filter, der dem Embryo den Zugang zu Nährstoffen ermöglicht, während er eine Barriere zu den Zellen der Mutter bildet (Gardner, 1983).
...
Despite constant progress in basic and translational research, cancer is still one of the leading cause of death. In particular, tumors of the central nervous system (CNS) are usually associated with dismal prognosis. Although about 100 distinct subtypes of primary CNS tumors have been classified molecularly, metastases derived from primaries outside the CNS (= brain metastases, BrM) are more frequently observed across brain tumor patients. It is estimated that approximately 20 - 40 % of all cancer patients will develop BrM during their course of disease, and basically every tumor type is able to metastasize to the brain. Nevertheless, BrM are most frequently derived from primaries of the lung, breast, and skin (melanoma). Treatment options for patients with BrM are very limited, and standard of care therapies include surgery, ionizing radiation (e.g. whole brain radio-therapy, WBRT), and some systemic and immuno-therapeutic approaches.
The brain represents a unique organ, which in part is due to the presence of the blood-brain barrier, a unit of the neuro-vascular interface ensuring tightly regulated exchange of nutrients, molecules, and cells. Furthermore, apart from microglia the brain parenchyma does not harbor other immune cells. Those cells however can be found at the borders of the CNS residing in the meninges, for instance. Based on recent insight on the immune landscape in the CNS, a paradigm shift occurred after which the brain is no longer regarded as immune-privileged but rather immune distinct. The phenomenon of immune cell infiltration has been described before in the context of neurological disorders including Multiple Sclerosis, as well as in brain tumors.
Since the development of immune-therapeutic approaches for tumors outside the CNS that aim to evoke sustainable anti-tumor effects, it became increasingly interesting to understand and harness the immune landscape (= tumor microenvironment, TME) of brain tumors, as well. Interestingly, most of the knowledge about the TME is based on studies of primary brain tumors. However, it is known that BrM compared to primary brain tumors induce a different TME like e.g. the recruitment of much more lymphocytes, which is one of the reasons primary brain tumors are considered immunologically “cold” and poorly respond to immuno-therapies. Previous insight into the functional contribution of tumor-associated cells in BrM progression revealed for example that brain-resident cell types (e.g. astrocytes or microglia) promote BrM development and outgrowth. However, until recently a comprehensive view on the cellular composition and functional role of the brain metastases-associated TME was missing and little was known how it changes during tumor progression or standard therapy.
Hence, within this thesis it was sought to describe novel aspects of the TME of preclinical BrM models, which include two xenograft and one syngeneic mouse model. BrM was induced via intra-cardiac injection of tumor cells with a high brain tropism. Both xenograft models were based on immuno-compromised nude mice (Balb/c nude) and included the melanoma-to-brain (M2B) model H1_DL2, and the lung-to-brain (L2B) model H2030. In addition the breast-to-brain model 99LN-BrM was used in wild-type mice (BL6), and therefore represented an immuno-competent, syngeneic model. First BrMs could be detected in the xenograft models at 3 weeks after injection, whereas first 99LN BrMs were detected at 5 weeks. BrM development and progression were monitored by bioluminescence imaging once per week in the xenograft models. Tumor progression in the 99LN model was examined by magnetic resonance imaging. Based on the measurement methods, and for further histologic and cytometric experiments, mice were stratified into groups with small or large BrMs, respectively. Some initial immuno-stainings confirmed previous findings, showing that brain-resident cells like astrocytes and microglia become activated in the presence of tumor cells, whereas neurons for example rather give the impression of passive bystanders. Importantly, an accumulation of IBA1+ cells was observed during BrM progression. IBA1 is a pan-macrophage marker that stains all tumor-associated macrophages (TAMs). However previous work suggested that the TAM population consists of at least two main subpopulations in BrM as well: the resident-infiltrating microglia (MG, TAM-MG), as well as the peripheral and monocytic-derived macrophages (TAM-MDM). Since both cell types within the tumor share morphological traits, and due to the lack of markers to distinguish them, an exact discrimination of both cell types was complicated in the past. Recently, an integrative lineage-tracing-based study identified the integrin CD49d as MDM-specific in the context of brain tumor-associated myeloid cells, hence enabling a reliable dissection of both TAM populations in e.g. flow cytometric experiments.
One of the main aims of this thesis was to dissect the myeloid TME in the three different BrM models during tumor progression. Using a 5-marker flow cytometry (FCM) (CD45/CD11b/Ly6C/Ly6G/CD49d) approach, the following cell populations were examined in more detail: granulocytes, inflammatory monocytes, MDM, and MG.
...
My PhD work employed genetic and pharmacological manipulations, coupled with highresolution live imaging, to understand intercellular communications during zebrafish cardiovascular development. The heart is the first organ to form, and it is composed of several tissues, among which interactions are crucial. I identified two important interactions between muscular and non-muscular tissues in poorly characterized contexts, and the molecules required for the signalling. First, I discovered an important cellular and molecular crosstalk orchestrating the development of the cardiac outflow tract (i.e., the aortic root in mammals).
Endothelial-derived TGF-beta signalling controls the generation of the local extracellular matrix (ECM). The ECM in turn affects endothelial proliferation as well as smooth muscle cell organization (Boezio et al, 2020; Bensimon-Brito*, Boezio* et al, 2020). In my second project, I investigated the crosstalk between the epicardial layer and the myocardial wall. By generating epicardial-impairment models, I identified a novel role for the epicardium in regulating cardiomyocyte volume during heart development (Boezio et al, 2021). Ultimately, this research contributed to our understanding of how paracrine signalling controls the multicellular interactions integral to organogenesis.
Subject of this thesis was the investigation of the actin-interacting and glucocorticoid-sensitive Protein DRR1 (or Fam107a) and its role in promoting stress resilience in the murine hippocampus.
We proposed the hypothesis that DRR1 through its actin-binding properties specifically modulates neuronal actin dynamics and promotes resilience through synaptic plasticity leading to subsequently improvement of cognitive performance and social behavior. The accompanied AMPA-receptor transport could create an efficient way regulating neural function and complex behavior during stress episodes.
By utilizing fluorescent immunohistochemistry, we showed basal expression of DRR1 primarily in the murine cerebellum and hippocampal CA3 and CA1 area. Co-staining with different cell marker proteins showed DRR1 expression in neurons, microglia and especially in astrocytic end-feet, which create contact to the brain vasculature.
To test whether DRR1 and AMPA receptor function correlate to modulate stress-associated consequences, primary hippocampal neuron cultures were transduced with adeno-associated virus (AAV) for overexpression or suppression of the protein. Western Blot analysis showed a positive correlation between the AMPA-receptor subunit GluR2 and DRR1 amounts. Further the application of the proximity ligation assay (PLA) in untreated neural cultures indicated interaction between DRR1 and the AMPA receptor subunit GluR2. To address whether DRR1 even affects AMPAR trafficking we performed the “newly inserted assay” after AAV-treatment of primary hippocampal neuron cultures. Suppression of DRR1 revealed less newly inserted GluR2 subunits as compared to controls. Inconclusive were the results upon DRR1 overexpression, however they point to no changes.
In the second part we correlated behavioral phenotypes originating from in vivo overexpression and suppression of DRR1 in the murine hippocampus with potential alterations in neuronal morphology. Therefore, in vitro analysis was performed utilizing AAV transduced primary hippocampal cultures overexpressing or suppressing DRR1. Synchronously the viral vector included a green fluorescent protein (GFP) being expressed throughout the complete neural cell. GFP staining was used to verify successful transfection and for reconstruction of dendritic arbors and dendritic stretches for spine classification. DRR1 suppression showed reduced total spine numbers especially evoked by reduced numbers of immature spine classes – namely long thin spines and filopodia. Whereas mature mushroom spines and stubby spines were unaffected. By overexpressing DRR1, tendencies inclined against higher total dendritic lengths, branch points and increased dendritic arbors in comparison to controls. In regard of spines, total numbers were unaffected. However, mature mushroom spines were significantly declined in numbers, but compensated by increased numbers of immature long thin spines and filopodia.
Chronic social defeat stress (CSDS) is widely used in mouse models to study the effects of stress and resilience. We exposed C57Bl/6J mice expressing GFP under the Thy1 promoter CSDS and categorized them into resilient (R+/-), susceptible (R-/-) and non-learning (R+/+) mice following a modified social interaction test (MSIT). We found alterations in CA1 spine compositions with resilient animals resembling the untreated phenotype. Stress susceptible and non-learning animals displayed reduced numbers in stubby spines with simultaneous increases in mature mushroom spines. In addition, we could detect a tendency towards more immature spines in susceptible animals and non-learners, mirroring our in vitro results.
Finally, we present a different investigative approach in this thesis. Sequenced acute stress was previously found to compromise cognition including spine loss.
We aimed to investigate the implication of acute stress on DRR1 levels and its occurrence in diverse cell types of the brain. We subjected one group of C57Bl/6J mice to acute stress and injected another group with the artificial glucocorticoid DEX. Six hours post stress, animals were perfused and brains were subsequently immunobiologically analyzed. We found DRR1 protein levels elevated in the hippocampus of stressed and DEX-treated animals compared to controls. Interestingly, DRR1 seemed was especially elevated in endothelial cells. This coincides with our investigations finding DRR1 present in astrocytic end-feet under basal conditions and might claim a participation of DRR1 in the blood-brain-barrier integrity.
Our results show DRR1 as actin-interacting and glucocorticoid-sensitive gene affecting structural plasticity of hippocampal spines. Moreover, DRR1 directly interacts with AMPA glutamate receptors and presumably is involved in AMPA trafficking to the postsynaptic membrane. In addition, this study could demonstrate that DRR1 is expressed by other cell types of the brain. Of special interest is DRR1’s occurrence in astrocytic end-feet and endothelial cells suggesting a role as integrator of cell-cell communication and to this end also acting as modifier of stress-induced consequences at the neurovascular unit.
In vivo data of chronically stressed mice displayed no phenotypic differences in hippocampal pyramidal neurons of resilient animals as compared to unstressed mice. Morphological alterations of spine structures were particularly visible in stress susceptible and non-learning animals. Integrating our findings with existing behavioral data, we can conclude that DRR1 plays a role in stress resilience whereby it needs to be expressed in a tightly managed homeostatic equilibrium.
Fungal organisms, including the most common human pathogens Candida spp., are commensal organisms that are widely present as part of the human flora. Fungal infections are, most frequently, local infections that do not compromise the life of patients. However, mycotic diseases can be life-threatening if they become systemic infections. Systemic fungal infections have risen over the last three decades in parallel to the increased immune-compromised population as a consequence of diseases (e.g. HIV/AIDS) or therapeutic interventions that affect the immune system (e.g. chemotherapy for cancer treatment and immunosuppressors used for patients with organ transplants). This has resulted in the demand of new antifungal drugs that can eradicate the new infections caused by these opportunistic fungal pathogens. However, most of the current compounds have poor pharmaceutical properties such as narrow spectrum of activity, susceptibility to be extruded by efflux pumps or lack of specificity, which make them not suitable for human clinical applications. The treatment of fungal and parasitic infections has been traditionally difficult because the infective organisms are eukaryotic cells that share most of the pathways and enzymes with human cells. To avoid side effects and to develop a targeted therapy, the research has traditionally been centered on the very few enzymes and pathways existing in the infectious organism but absent in humans. Until now, antifungal therapeutic options are limited and are almost dominated by azole class of sterol biosynthesis inhibitors affecting the synthesis of ergosterol, a major constituent of the fungal cell membrane. Because human cells do not have a cell wall, the development of effective and safe antifungal agents has also been directed to enzymes required for the synthesis of the cell wall. Alternatively, it is theoretically possible to target enzymes that are present in fungal organisms and in humans, when: 1) sufficient selectivity can be achieved, and 2) inhibition of the fungal enzyme is lethal to the fungus but does not produce major side effects to humans. In this line, it would be ideal to evaluate the development of selective inhibitors of enzymes which are already known to be drug targets, like protein kinases.
This thesis reports on the results obtained by expression photoactivatable adenylyl cyclase from Beggiatoa spp. (bPAC) in cholinergic neurons from Caenorhabditis elegans (C. elegans) and the characterization of the role of a single neuron, RIS, during locomotion in the adult animal.
Pharmacological activation of adenylyl cyclases through Forskolin is known to induce increased neuronal output in diverse model organisms through a protein kinase A (PKA) dependent mechanism. Nevertheless, pharmacological assays are not spatially restricted, do not allow for precise and acute activation nor to cessation of the signal. Thus, an optogenetic approach for was selected trough the expression of photoactivatable adenylyl cyclase from Beggiatoa spp. (bPAC) in cholinergic neurons of Caenorhabditis elegans (C. elegans). This model organism was chosen due to its transparency, ease of maintenance, fast generation cycles as well as for being an eutelic animal. Further, its genome has been fully sequenced and the connectome of the neuronal network is known, thus allowing for precise analysis of neuronal function. Furthermore, the molecular mechanisms governing neuronal functions are well conserved up to primates. Mainly two optogenetical tools were applied, bPAC and the light gated cation channel channelrhodopsin 2 (ChR2).
Behavioral assays of bPAC photostimulation in cholinergic neurons recapitulated previous work performed with the photoactivatable adenylyl cyclase from Euglena gracilis (EuPACa), in which swimming frequency and speed on solid substrate were increased. Electrophysiological recordings of body wall muscle (BWM) cells by Dr. Jana F. Liewald showed that bPAC photoactivation led to an increase in miniature postsynaptic current (mPSC) rate and, in contrast to ChR2 invoked depolarization, also amplitude. Analysis of mutants deficient in neuropeptidergic signaling (UNC- 31) via electrophysiology performed by Dr. Jana F. Liewald showed that the increase in mPSC amplitude due to bPAC photoactivation requires neuropeptide release. This was confirmed by co-expression of bPAC with the neuropeptide marker NLP-21::Venus and subsequent fluorescence analysis of release, exploiting the fact that released neuropeptides are ultimately degraded by scavenger cells (coelomocytes). These were enriched with NLP-21::Venus after bPAC photostimulation, but no fluorescence could be observed in the UNC-31 mutants.
Additional analysis of the electrophysiological data performed by myself showed no modulation of mPSC kinetics dues to neuropeptidergic release induced by bPAC. Hence, neuropeptide release and action sites were in the cholinergic neurons, the latter including cholinergic motoneurons.
Dr. Szi-chieh Yu provided electron microscopy images of high pressure frozen, bPAC or ChR2 expressing animals. These were tagged by myself for automatic analysis of ultrastructural properties of the cholinergic presynapse, also during photoactivation of both optogenetic tools. Photoactivation of both induced a reduction of synaptic vesicles, with ChR2 showing a more severe effect. In contrast to ChR2, though, bPAC also reduced the amount of dense core vesicles (DCV), the neuropeptide transporters. Additionally, long bPAC photoactivation as well as ChR2 photoactivation led to the appearance of large vesicles (LV), presumably in response to the increased SV fusion rate. bPAC photostimulation also induced an increase in SV size, not observed after ChR2 photostimulation. In UNC-31 mutants, bPAC photostimulation could not lead to the SV size increase, a further argument for the presynaptic effect of the released neuropeptide. Additional analysis of electrophysiology paired with pharmacology, performed by Dr. Jana F. Liewald, showed that mPSC amplitude increase requires the function of the vesicular acetylcholine transporter.
A further effect observed in the ultrastructure of bPAC photostimulated cholinergic presynapses was a shift in the distribution of SV regarding the dense projection. An analysis of cAMP pathway mutants showed that synapsin is required for bPAC induced behavior effects. Synapsin is known to mediate SV tethering to the cytoskeleton. Here, I show evidence for a new role of synapsin in controlling the availability of DCVs for fusion and thus, in neuropeptidergic signaling.
In the second part of my thesis I characterized the function of the GABAergic interneuron RIS in the neuronal network of C. elegans. RIS was shown to induce lethargus, a sleep-like state, during all larval molts, but its function in the adult animal was not yet described. Specific RIS expression of ChR2 achieved by a recombinase based system allowed to acutely depolarize the neuron during locomotion, which led to an acute behavioral stop. Diverse signal transduction pathway mutants were analyzed showing that the phenotype was induced by neuropeptidergic signaling. Through mutagenesis followed by whole genome sequencing data analysis as well as analysis of RIS specific RNA sequencing data further narrowed the signal transduction pathway to mediate the locomotion stop behavior. Since the neuropeptide and, to some extent, the neuron are conserved across nematodes, an argument is outlined in favor of the conservation of this sleep-like state.
In addition, since ChR2 could induce neuropeptidergic signaling from RIS, secretion of vesicles is regulated by variable pathways depending on the neuronal identity. Nevertheless, expression of bPAC in RIS allowed to optogenetically increase the probability of short stops, as observed by expression of a calcium sensor (GCaMP) in RIS and analysis of its intrinsic activity in the adult animal.
The heart is the first functional organ that develops in the embryo. To become a functional organ, it undergoes several morphogenetic processes. These morphogenetic events involve different cell types, that interact with each other and respond to the surrounding extracellular matrix, as well as intrinsic and extrinsic mechanical forces, assuming different behaviors. Additionally, transcription factor networks, conserved among vertebrates, control the development.
To have a better understanding of cell behavior during development, it is necessary to find a model system that allows the investigation in vivo and at single-cell resolution. Thanks to the common evolutionary origin of the different cardiac structures, together with the conserved molecular pathways, the two-chambered zebrafish heart offers many advantages to study cell behavior during cardiac morphogenesis. Here, using the zebrafish heart as a model system, I uncovered the cell behavior behind two of the main cardiac morphogenetic events: cardiac wall maturation and cardiac valve formation.
In the first part of this study, I investigated how the cardiac wall is maintained at the molecular level. Using genetic, transcriptomic, and chimeric analyses in zebrafish, we find that Snai1b is required for myocardial wall integrity. Global loss of snai1b leads to the extrusion of CMs away from the cardiac lumen, a process we show is dependent on cardiac contractility. Examining CM junctions in snai1b mutants, we observed that N-cadherin localization was compromised, thereby likely weakening cell-cell adhesion. In addition, extruding CMs exhibit increased actomyosin contractility basally, as revealed by the specific enrichment of canonical markers of actomyosin tension - phosphorylated myosin light chain (active myosin) and the α-catenin epitope α-18. By comparing the transcriptome of wild-type and snai1b mutant hearts at the early stages of CM extrusion, we found the dysregulation of intermediate filament genes in mutants including the upregulation of desmin b. We tested the role of desmin b in myocardial wall integrity and found that CM-specific desmin b overexpression led to CM extrusion, recapitulating the snai1b mutant phenotype. Altogether, these results indicate that Snai1 is a critical regulator of intermediate filament gene expression in CMs and that it maintains the integrity of the myocardial epithelium during embryogenesis, at least in part by repressing desmin b expression.
In the second part of this study, I focused on the behavior of valve cells during cardiac development. Using the zebrafish atrioventricular valve, I focus on the valve interstitial cells which confer biomechanical strength to the cardiac valve leaflets. We find that initially AV endocardial cells migrate collectively into the cardiac jelly to form a bilayered structure; subsequently, the cells that led this migration invade the extracellular matrix (ECM) between the two EC monolayers, undergo an endothelial-to-mesenchymal transition as marked by loss of intercellular adhesion, and differentiate into VICs. These cells proliferate and are joined by a few neural crest-derived cells. VIC expansion and a switch from a pro-migratory to an elastic ECM drive valve leaflet elongation. Functional analysis of Nfatc1 reveals its requirement during VIC development. Zebrafish nfatc1 mutants form significantly fewer VICs due to reduced proliferation and impaired recruitment of endocardial and neural crest cells during the early stages of VIC development. Analysis of downstream effectors reveals that Nfatc1 promotes the expression of twist1b, a well-known regulator of epithelial-to-mesenchymal transition. This study shows for the first time that Nfatc1 regulates zebrafish VICs formation regulating valve EMT in part by regulating twist1b expression. Moreover, it proposes the zebrafish valve as an excellent model to study the cellular and molecular process that regulate VIC development and dysfunction.
In conclusion, my work: 1) identified an unsuspected role of Snai1 in maintaining the integrity of the myocardial epithelium, opening new avenues in its role in regulating cellular contractility; 2) uncovered the function of Nfatc1 in the establishment of the VIC, establishing a new model to study valve development and function.
NOSTRIN belongs to the recently defined F-BAR protein family. F-BAR proteins are
multi-domain proteins, which serve as adaptors between plasma membrane and
cytoskeleton components in processes such as membrane protrusion formation,
endocytosis and migration. NOSTRIN encompasses a F-BAR domain at the N-terminus,
which mediates membrane association, followed by a HR1 motif and an intermediate
domain (ID) domain in the middle, and a SH3 domain at the C-terminus. The domain
architecture and ability to form oligomers enable NOSTRIN to coordinate several
interaction partners namely dynamin, caveolin, N-WASP and endothelial nitric oxide
synthase (eNOS) in the process of eNOS trafficking. In this context NOSTRIN was
originally identified and hence termed eNOS traffick inducer. NOSTRIN is expressed in
vascularized tissues (e.g. liver and lung) and in primary endothelial cells.
Aims of the present work were (1) to investigate if NOSTRIN is involved in other
processes besides eNOS trafficking, (2) to analyse the function of NOSTRIN in vivo
through knockdown of NOSTRIN in developing zebrafish and (3) to study the
consequences of the loss of NOSTRIN on signal transduction in a primary cell culture
model derived from NOSTRIN knockout mice.
To study the possible involvement of NOSTRIN in other processes besides eNOS
trafficking a yeast two-hybrid screen was performed in which fibroblast growth factor
receptor 1 (FGFR1) was identified as a putative novel interaction partner of NOSTRIN. In
a series of yeast two-hybrid, pulldown and co-immunoprecipitation experiments the
interaction between NOSTRIN and FGFR1 was confirmed to occur between
endogenously expressed proteins and determined to be direct and to depend on the ID
domain of NOSTRIN and the 130 C-terminal amino acid residues of FGFR1. FGFR1 is
activated by binding of fibroblast growth factors (FGFs) and induces several different
signal transduction pathways (e.g. MAPK and Akt pathway). Overexpression of
NOSTRIN in HeLa cells specifically enhanced FGF2-dependent MAPK activation.
Accordingly, depletion of NOSTRIN attenuated FGF2-dependent MAPK activation and
did not affect FGF2-induced Akt activation.
In summary, NOSTRIN has been identified as a novel interaction partner of FGFR1
involved in FGF2-dependent signal transduction.
The morpholino oligonucleotide-mediated knockdown of NOSTRIN in developing
zebrafish caused vascular leakage and irregular vascular patterning e.g. a loss of the
proper trajectory of intersegmental vessel and interruptions of the dorsal longitudinal
anastomotic vessel. The vascular phenotype was consistent upon use of two different
morpholinos and could be rescued in a dose dependent manner by the injection of
zebrafish NOSTRIN mRNA. Detailed analysis involving confocal and time lapse
microscopy in zebrafish with endothelial specific expression of EGFP revealed that the
knockdown of NOSTRIN impacts in vivo on the migration and morphology of endothelial
tip cells and leads to a reduction of filopodia number and length.
Additionally a NOSTRIN knockout mouse was generated. The analysis of FGFR1 signal
transduction in primary mouse lung endothelial cells (MLECs) from NOSTRIN knockout
and wild type mice revealed that FGF2-dependent MAPK activation was attenuated in
MLECs isolated from NOSTRIN knockout mice when compared to MLECs isolated from
wild type mice. The effect of NOSTRIN on FGF2-dependent signal transduction seems to
be specific, since VEGF-induced MAPK activation was not affected in NOSTRIN
knockout MLECs. The importance of NOSTRIN for FGF2 signal transduction in vivo is
demonstrated by the greatly impaired angiogenic response to FGF2 in NOSTRIN
knockout mice in matrigel plug assay. In a detailed biochemical analysis it was
discovered that NOSTRIN interacts with the activated small GTPase Rac1 and that
overexpression of NOSTRIN enhances Rac1 activation. Furthermore, the interactions of
NOSTRIN with both Rac1 and its GEF Sos1 are required for NOSTRIN-mediated
activation of Rac1. In accordance, activation of Rac1 was not detected upon FGF2
stimulation in NOSTRIN knockout MLECs.
In conclusion, the present work describes a novel function of the F-BAR protein
NOSTRIN in FGFR1 signal transduction. Data presented in this work demonstrate that
NOSTRIN is required for the assembly of a complex consisting of FGFR1, Sos1 and
Rac1 and subsequently for the FGF2-dependent activation of Rac1 in endothelial cells.
Application of a developed tool to visualize newly synthesized AMPA receptor components in situ
(2018)
The information flow between neurons happens at contact points, the synapses. One underlying mechanism of learning and memory is the change in the strength of information flow in selected synapses. In order to match the huge demand in membranes and proteins to build and maintain the neurites' complex architecture, neurons use decentralized protein synthesis. Many candidate proteins for local synthesis are known, and the need of de novo synthesis for memory formation is well established. The underlying mechanisms of how somatic versus dendritic synthesis is regulated are yet to be elucidated. Which proteins are newly synthesized in order to allow learning?
In this thesis protein synthesis is studied in hippocampal neurons. The fractional distribution of somatic and dendritic synthesis for candidate proteins and their subsequent transport to their destination are investigated using a newly developed technique. In the first part of this study we describe the development of this technique and use it in the second part to answer biological questions.
We focus here on AMPA receptor subunits, the key players in fast excitatory transmission. AMPA receptors contain multiple subunits with diverse functions. It remains to be understood, when and where in a neuron these subunits come together to form a protein complex and how the choice of subunits is regulated.
The investigation of the subunits' site of synthesis and redistribution kinetics in this study will help us to understand how neurons are able to change their synaptic strength in an input specific manner which eventually allows learning and memory.
Key questions which are addressed in this study:
How can specific newly synthesized endogenous proteins be visualized in situ? What are the neuron's abilities to locally synthesize and fully assemble AMPA receptor complexes?
How fast do different AMPA receptor subunits redistribute within neurons after synthesis?